Description
Perjeta (pertuzumab) is a monoclonal antibody targeting HER2, used with trastuzumab and chemotherapy for HER2-positive breast cancer.
$3,445.63
HER2-targeted therapy for breast cancer
Perjeta (pertuzumab) is a monoclonal antibody targeting HER2, used with trastuzumab and chemotherapy for HER2-positive breast cancer.
Reviews
There are no reviews yet.